Cargando…
Metabolic Modeling Identifies a Novel Molecular Type of Glioblastoma Associated with Good Prognosis
Glioblastoma (GBM) is one of the most aggressive forms of cancer. Although IDH1 mutation indicates a good prognosis and a potential target for treatment, most GBMs are IDH1 wild-type. Identifying additional molecular markers would help to generate personalized therapies and improve patient outcomes....
Autores principales: | Shen, Qiu, Yang, Hua, Kong, Qing-Peng, Li, Gong-Hua, Li, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964559/ https://www.ncbi.nlm.nih.gov/pubmed/36837790 http://dx.doi.org/10.3390/metabo13020172 |
Ejemplares similares
-
Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma
por: Liu, Rongrong, et al.
Publicado: (2022) -
Re-Irradiation and Its Contribution to Good Prognosis in Recurrent Glioblastoma Patients
por: Kim, Mi Sun, et al.
Publicado: (2020) -
Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma
por: Yin, Wen, et al.
Publicado: (2019) -
Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas
por: Song, Xue, et al.
Publicado: (2018) -
Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma
por: Guo, Rui-Ming, et al.
Publicado: (2018)